Posts from ‘April, 2009’

NEW YORK, April 23 (HSMN NewsFeed) — Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today announced the appointment of Michael P. Tarnok to be its interim Chairman and Chief Executive Officer, replacing Michael S. Weiss, effective immediately. Mr. Ta…
Biopharmaceuticals, Personnel
Keryx Biopharmaceuticals

SADDLE RIVER, N.J.–(HSMN NewsFeed)–PDI, Inc. (NASDAQ: PDII ), a pioneer in providing contract sales and commercialization services to the biopharmaceutical industry, today announced that PDI and Novartis have agreed to terminate a promotion agreement tha…
Biopharmaceuticals
PDI, Novartis

Lilly Continues to Defend Intellectual Property Rights for Evista INDIANAPOLIS, April 22 (HSMN NewsFeed) — Eli Lilly and Company (NYSE: LLY ) announced that the U.S. District Court for the Southern District of Indiana today issued a preliminary injun…
Biopharmaceuticals, Generics, Litigation
Eli Lilly, Teva Laboratory, Evista , raloxifene, osteoporosis

SUNRISE, FL–Apr 22, 2009 — At the recent Charing Cross Symposium in London, Bolton Pharma announced the launch of a new and further improved delivery system: RELAY Plus. The new delivery system is designed for use with the highly successful RELAY Thora…
Devices, Interventional, Regulatory
Bolton Pharma, Thoracic Stent-Graft, aortic aneurysm

MediciNova’s Phase II Placebo-controlled Clinical Trial (MN-221-CL-007) Evaluating MN-221 in Patients with Severe, Acute Exacerbations of Asthma is Actively Enrolling Patients SAN DIEGO, April 22, 2009 –(HSMN NewsFeed) — MediciNova, Inc., a biopharmac…
Biopharmaceuticals
MediciNova, MN-221, asthma

Open System Helps Ensure Code Readiness CHELMSFORD, Mass.–(HSMN NewsFeed)–ZOLL Pathology Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, has received clearance from the State Food and Drug Administr…
Devices, Regulatory
ZOLL Medical, ZOLL R Series, defibrillators

NORTH HAVEN, Conn.–(HSMN NewsFeed)–Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that it has filed a lawsuit in the United States District Court for the District of Delaware against Davol, Inc., a wholl…
Devices, Litigation
Covidien, Davol, C.R. Bard, Sorbafix

SALT LAKE CITY, UT–Apr 21, 2009 — Paradigm Medical Industries, Inc. (OTC BB:PDMI.OB ) announced today that the Company is expanding its domestic and international reach with the addition of 10 new independent sales representatives in the United States. …
Devices, Ophthalmology
Paradigm Clinical Industries

FORT WORTH, Texas, April 21 (HSMN NewsFeed) — Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM ), announced today that it has entered into an agreement with Quad Xenos Partners, LLC (QX Senior partners…
Devices, Wound Care, Distribution
Wound Management Technologies, Quad Xenos Partners, CellerateRx

The Ohio State University Clinical Center Implants 2 Patients with Sunshine Heart’s C-Pulse(TM) Heart Assist System Under FDA-Approved Clinical Trial SYDNEY, and TUSTIN, Calif., April 21 (HSMN NewsFeed) — Sunshine Heart (ASX: SHC ), a global clinical laboratory…
Devices, Cardiology
Sunshine Heart, C-Pulse, heart assist, cardiac assist, heart failure